Geopolitical & Trade Policy Impact on S K AGE Exports's Ketoconazole Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like S K AGE Exports. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased shipping costs and extended transit times. These disruptions have resulted in freight inflation, with transport charges doubling and surcharges ranging from $4,000 to $8,000 per shipment. (pharmaceuticalcommerce.com) Such logistical challenges can impact the timely delivery of pharmaceuticals, particularly to markets in the Middle East and North Africa.
Conversely, US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. India supplies 47% of the US's generic drugs, underscoring its critical role in the American healthcare system. (orfonline.org) However, the imposition of tariffs on Indian pharmaceutical products by the US poses a risk, potentially leading to reduced export volumes and increased compliance costs. (transdatanexus.com)
In the European Union, the implementation of the Falsified Medicines Directive (FMD) necessitates stringent compliance measures. Indian exporters must ensure adherence to these regulations to maintain market access. The India–EFTA Trade and Economic Partnership Agreement, effective from October 1, 2025, aims to eliminate or reduce tariffs on goods traded between India and EFTA countries, potentially enhancing market opportunities for exporters like S K AGE Exports. (en.wikipedia.org)
S K AGE Exports — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. India has made significant strides in this area, with 752 FDA-approved, 2,050 WHO GMP-certified, and 286 EDQM-approved manufacturing facilities as of 2024. (ibef.org) Instances of non-compliance have decreased, indicating improved adherence to quality standards. For S K AGE Exports, maintaining such compliance is essential to ensure uninterrupted market access and to uphold the company's reputation in the global pharmaceutical industry.
